Filing Details

Accession Number:
0000897069-23-001850
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-27 17:33:10
Reporting Period:
2023-11-20
Accepted Time:
2023-12-27 17:33:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1904286 Mira Pharmaceuticals Inc. MIRA Pharmaceutical Preparations (2834) 853354547
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1986593 Trust Shore Bay 855 N Wolfe Street
Suite 601
Baltimore MD 21205
No No No No
1996353 Patrick Brian Mcnulty 855 N Wolfe Street
Suite 601
Baltimore MD 21205
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-20 13,367 $5.07 2,845,951 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-21 2,500 $5.00 2,843,451 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-27 3,213 $4.00 2,840,238 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-28 121 $4.00 2,840,117 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-29 3,699 $3.98 2,836,418 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-30 2,421 $3.77 2,833,997 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-04 30,665 $3.98 2,803,332 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-06 13,867 $2.95 2,789,465 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-07 16,666 $1.89 2,772,799 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-08 9,526 $1.61 2,763,273 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-11 23,003 $1.55 2,740,270 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-20 13,366 $5.07 765,681 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-21 2,500 $5.00 763,181 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-27 3,212 $4.00 759,969 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-28 120 $4.00 759,849 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-29 3,700 $3.98 756,149 No 4 S Indirect By Trust
Common Stock Disposition 2023-11-30 2,421 $3.77 753,728 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-04 30,666 $3.98 723,062 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-06 13,866 $2.95 709,196 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-07 16,667 $1.89 692,529 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-08 9,527 $1.61 683,002 No 4 S Indirect By Trust
Common Stock Disposition 2023-12-11 23,002 $1.55 660,000 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Footnotes
  1. These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.
  2. These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.